+454.2%
MRNA vs MOS
-17.6%
+471.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MOS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -1.2% | -2.2% | -2.7% |
| 7D | -10.1% | +1.7% | -11.7% | -11.0% |
| 30D | +126.7% | +11.7% | +115.1% | +105.1% |
| 3M | +184.1% | +23.2% | +161.0% | +152.5% |
| 6M | +143.3% | -1.6% | +144.9% | +120.5% |
| YTD | +359.9% | +10.8% | +349.0% | +314.8% |
| 1Y | +454.2% | -16.2% | +470.4% | +408.5% |
| All | +454.2% | -17.6% | +471.8% | +408.5% |
Cumulative growth
Daily Returns
Daily percentage return beside MOS.
Daily Out/Under-Performance
Portfolio return minus MOS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MOS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MOS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling